Skip to main content
. 2023 Jun 1;9(6):e16171. doi: 10.1016/j.heliyon.2023.e16171

Fig. 4.

Fig. 4

Current famotidine versus past famotidine users among all patients who were tested for SARS-CoV-2. After matching, the blue and red lines are nearly overlapping, as observed. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)